Granahan Investment Management’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-176,683
Closed -$1.16M 188
2021
Q3
$1.16M Sell
176,683
-184,272
-51% -$1.16M 0.02% 185
2021
Q2
$2.4M Buy
360,955
+20,008
+6% +$124K 0.04% 178
2021
Q1
$1.95M Sell
340,947
-124,848
-27% -$924K 0.04% 173
2020
Q4
$4.16M Sell
465,795
-128,072
-22% -$1.37M 0.09% 142
2020
Q3
$6.91M Buy
593,867
+263,120
+80% +$3.82M 0.23% 91
2020
Q2
$5.3M Buy
330,747
+29,022
+10% +$322K 0.19% 105
2020
Q1
$1.81M Sell
301,725
-3,433
-1% -$31.7K 0.1% 141
2019
Q4
$4.03M Buy
305,158
+543
+0.2% +$7.11K 0.19% 102
2019
Q3
$3.78M Buy
304,615
+28,794
+10% +$381K 0.21% 103
2019
Q2
$4.44M Buy
275,821
+185,778
+206% +$4.15M 0.22% 94
2019
Q1
$2.83M Sell
90,043
-6,407
-7% -$182K 0.15% 131
2018
Q4
$3.17M Sell
96,450
-4,312
-4% -$142K 0.22% 106
2018
Q3
$3.09M Buy
100,762
+3,347
+3% +$90.4K 0.17% 126
2018
Q2
$2.61M Buy
+97,415
New +$2.57M 0.16% 144

Other funds holding AUTL

Granahan Investment Management's AUTL Position: Q4 2021 in Review

Granahan Investment Management sold out of Autolus Therapeutics (AUTL) in Q4 2021, closing a stake of 176,683 shares — an estimated $1.16M sold.

Granahan Investment Management first reported a position in AUTL in Q2 2018 and held it in 14 quarters. The position peaked at $6.91M in Q3 2020. 73 funds tracked by Wall St. Rank hold AUTL as of Q4 2021.

  • Granahan Investment Management reported no remaining Autolus Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Granahan Investment Management sold 176,683 Autolus Therapeutics shares in Q4 2021, an estimated $1.16M.
  • Granahan Investment Management first reported a position in Autolus Therapeutics in Q2 2018 and held it in 14 quarters.
  • Granahan Investment Management's Autolus Therapeutics position peaked at $6.91M in Q3 2020.
  • 73 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.